Literature DB >> 20972876

Impact of minimising door-to-balloon times in ST-elevation myocardial infarction to less than 30 min on outcome: an analysis over an 8-year period in a tertiary care centre.

Ulrike M Müller1, Ingo Eitel, Kristina Eckrich, Sandra Erbs, Axel Linke, Sven Möbius-Winkler, Meinhard Mende, Gerhard C Schuler, Holger Thiele.   

Abstract

BACKGROUND: Guidelines recommend door-to-balloon times (DBTs) below 60 min for patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). The purpose of this study was to determine if an optimised STEMI-protocol reduces DBT and increases the number of patients to receive PCI within 60 min of hospital presentation. We hypothesised that DBT of <30 min can be accomplished for the majority of patients. METHODS AND
RESULTS: Between 2001 and 2008 data from 1,146 consecutive patients with acute STEMI admitted for primary PCI within 12 h after symptom-onset were analysed. Times to angioplasty from symptom-onset (pain-to-balloon time, PBT) and from hospital arrival (DBT) to PCI and clinical outcomes were analysed. In the end of 2003 numerous strategies were implemented to reduce revascularisation times. These strategies resulted in a stable reduction of median DBT to 29 min [interquartile range (IQR) 22-39]. Overall, 94% of patients had median DBT < 60 min and 56% <30 min. Consequently, PBT was significantly reduced from median 218 min (IQR 168-286) to 167 min (IQR 119-245) for non-transferred patients. Major cardiac adverse events (composite of congestive heart failure, reinfarction and cardiac death) were significantly associated with DBT > 30 min and age, systolic blood pressure, anterior infarction, PBT > 4 h, cardiogenic shock as well as multivessel disease.
CONCLUSIONS: A dedicated STEMI-protocol including several hospital strategies is feasible during daily clinical practice to decrease revascularisation times, results in a greater proportion of patients achieving guideline recommendations, and is associated with an improved clinical outcome.

Entities:  

Mesh:

Year:  2010        PMID: 20972876     DOI: 10.1007/s00392-010-0242-7

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  34 in total

1.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.

Authors:  E M Antman; M Cohen; P J Bernink; C H McCabe; T Horacek; G Papuchis; B Mautner; R Corbalan; D Radley; E Braunwald
Journal:  JAMA       Date:  2000-08-16       Impact factor: 56.272

2.  Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go.

Authors:  Kim A Eagle; Brahmajee K Nallamothu; Rajendra H Mehta; Christopher B Granger; Philippe Gabriel Steg; Frans Van de Werf; Jose López-Sendón; Shaun G Goodman; Ann Quill; Keith A A Fox
Journal:  Eur Heart J       Date:  2008-03       Impact factor: 29.983

Review 3.  A campaign to improve the timeliness of primary percutaneous coronary intervention: Door-to-Balloon: An Alliance for Quality.

Authors:  Harlan M Krumholz; Elizabeth H Bradley; Brahmajee K Nallamothu; Henry H Ting; Wayne B Batchelor; Eva Kline-Rogers; Amy F Stern; Jason R Byrd; John E Brush
Journal:  JACC Cardiovasc Interv       Date:  2008-02       Impact factor: 11.195

Review 4.  Comparison of outcomes (early and six- month) of direct stenting with conventional stenting (a meta-analysis of ten randomized trials).

Authors:  Francesco Burzotta; Carlo Trani; Francesco Prati; Martial Hamon; Mario Attilio Mazzari; Rocco Mongiardo; Remi Sabatier; Alessandro Boccanelli; Giovanni Schiavoni; Filippo Crea
Journal:  Am J Cardiol       Date:  2003-04-01       Impact factor: 2.778

5.  Differential diagnosis of suspected apical ballooning syndrome using contrast-enhanced magnetic resonance imaging.

Authors:  Ingo Eitel; Florian Behrendt; Kathrin Schindler; Dietmar Kivelitz; Matthias Gutberlet; Gerhard Schuler; Holger Thiele
Journal:  Eur Heart J       Date:  2008-09-27       Impact factor: 29.983

6.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction).

Authors:  Elliott M. Antman; Daniel T. Anbe; Paul Wayne Armstrong; Eric R. Bates; Lee A. Green; Mary Hand; Judith S. Hochman; Harlan M. Krumholz; Frederick G. Kushner; Gervasio A. Lamas; Charles J. Mullany; Joseph P. Ornato; David L. Pearle; Michael A. Sloan; Sidney C. Smith; Joseph S. Alpert; Jeffrey L. Anderson; David P. Faxon; Valentin Fuster; Raymond J. Gibbons; Gabriel Gregoratos; Jonathan L. Halperin; Loren F. Hiratzka; Sharon Ann Hunt; Alice K. Jacobs; Joseph P. Ornato
Journal:  J Am Coll Cardiol       Date:  2004-08-04       Impact factor: 24.094

7.  Prognostic value of minimal blood flow restoration in patients with acute myocardial infarction after reperfusion therapy.

Authors:  Gjin Ndrepepa; Dritan Keta; Stefanie Schulz; Robert A Byrne; Julinda Mehilli; Jürgen Pache; Melchior Seyfarth; Albert Schömig; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2009-09-10       Impact factor: 5.460

8.  Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging.

Authors:  Holger Thiele; Mathias J Kappl; Axel Linke; Sandra Erbs; Enno Boudriot; Alexander Lembcke; Dietmar Kivelitz; Gerhard Schuler
Journal:  Eur Heart J       Date:  2007-06-06       Impact factor: 29.983

9.  Door-to-balloon times in hospitals within the get-with-the-guidelines registry after initiation of the door-to-balloon (D2B) Alliance.

Authors:  Brahmajee K Nallamothu; Harlan M Krumholz; Eric D Peterson; Wenqin Pan; Elizabeth Bradley; Amy F Stern; Frederick A Masoudi; David M Janicke; Adrian F Hernandez; Christopher P Cannon; Gregg C Fonarow
Journal:  Am J Cardiol       Date:  2009-02-28       Impact factor: 2.778

10.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Authors:  Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

View more
  14 in total

1.  A prospective, randomized trial of continuous lateral rotation ("kinetic therapy") in patients with cardiogenic shock.

Authors:  Gregor Simonis; Kerstin Steiding; Kerstin Schaefer; Thomas Rauwolf; Ruth H Strasser
Journal:  Clin Res Cardiol       Date:  2012-06-23       Impact factor: 5.460

2.  First clinical evaluation of a novel capacitive ECG system in patients with acute myocardial infarction.

Authors:  Mareike B Weil; Martin Oehler; Meinhard Schilling; Lars S Maier
Journal:  Clin Res Cardiol       Date:  2011-11-08       Impact factor: 5.460

3.  As time goes by?: the fallacy of thrombolysis in STEMI networks.

Authors:  Wolfgang von Scheidt; Christian Thilo
Journal:  Clin Res Cardiol       Date:  2011-06-30       Impact factor: 5.460

4.  The patient's interpretation of myocardial infarction symptoms and its role in the decision process to seek treatment: the MONICA/KORA Myocardial Infarction Registry.

Authors:  Inge Kirchberger; Margit Heier; Rupert Wende; Wolfgang von Scheidt; Christa Meisinger
Journal:  Clin Res Cardiol       Date:  2012-05-23       Impact factor: 5.460

5.  Maladaptive hypertrophy after acute myocardial infarction positive effect of bone marrow-derived stem cell therapy on regional remodeling measured by cardiac MRI.

Authors:  Andreas Rolf; Birgit Assmus; Volker Schächinger; Johannes Rixe; Susanne Möllmann; Helge Möllmann; Stefanie Dimmeler; Andreas M Zeiher; Christian W Hamm; Thorsten Dill
Journal:  Clin Res Cardiol       Date:  2011-06-17       Impact factor: 5.460

6.  Myocardial salvage in acute myocardial infarction--challenges in clinical translation.

Authors:  Daria Mochly-Rosen; Kevin V Grimes
Journal:  J Mol Cell Cardiol       Date:  2011-08-12       Impact factor: 5.000

7.  Incidence and distribution of occluded culprit arteries and impact of coronary collaterals on outcome in patients with non-ST-segment elevation myocardial infarction and early invasive treatment strategy.

Authors:  Philipp Bahrmann; Justus Rach; Steffen Desch; Gerhard C Schuler; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2010-12-17       Impact factor: 5.460

8.  Efficacy and limitations of a STEMI network: 3 years of experience within the myocardial infarction network of the region of Augsburg - HERA.

Authors:  Christian Thilo; Andreas Blüthgen; Wolfgang von Scheidt
Journal:  Clin Res Cardiol       Date:  2013-09-06       Impact factor: 5.460

9.  Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial.

Authors:  Georg Fuernau; Karl Fengler; Steffen Desch; Ingo Eitel; Franz-Josef Neumann; Hans-Georg Olbrich; Antoinette de Waha; Suzanne de Waha; Gert Richardt; Marcus Hennersdorf; Klaus Empen; Rainer Hambrecht; Christian Jung; Michael Böhm; Janine Pöss; Ruth H Strasser; Steffen Schneider; Taoufik Ouarrak; Gerhard Schuler; Karl Werdan; Uwe Zeymer; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2016-07-04       Impact factor: 5.460

10.  TNF-α, myocardial perfusion and function in patients with ST-segment elevation myocardial infarction and primary percutaneous coronary intervention.

Authors:  Eva S Kehmeier; Wolfgang Lepper; Martina Kropp; Christian Heiss; Ulrike Hendgen-Cotta; Jan Balzer; Mirja Neizel; Christian Meyer; Marc W Merx; Pablo E Verde; Christian Ohmann; Gerd Heusch; Malte Kelm; Tienush Rassaf
Journal:  Clin Res Cardiol       Date:  2012-05-06       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.